BPG致力于知识发现和传播
预出版
2020/12/21 3:07:01 | Browse: 95 | 下载: 135
Publication Name 世界华人消化杂志
手稿编号 37982
手稿来源省、自治区或特别行政区 湖北省
专业类型 消化内科学
手稿栏目类型 文献综述
文章标题 急性重症溃疡性结肠炎的治疗
手稿来源 自由来稿
所有作者列表 李俊蓉, 凌方梅, 陈翌东, 徐明旸, 朱良如
基金项目及其编号
通讯作者 朱良如, 博士, 教授, 主任医师, 430022, 武汉市江汉区解放大道1277号, 华中科技大学同济医学院附属协和医院消化内科. zhuliangru@hust.edu.cn
关键词 急性重症溃疡性结肠炎; 激素; 抢救治疗; 强化诱导治疗; 结肠切除术
核心内容提要 对于急性重症溃疡性结肠炎(acute severe ulcerative colitis, ASUC)的治疗, 目前激素仍是首选药物, 治疗3 d后应及时评估疗效; 疗效欠佳时应及时转换为抢救治疗方案, 常用药物为英夫利昔单抗与环孢素; 若经过4-7 d的抢救治疗仍无效, 可考虑结肠切除术. 此外, 托法替尼、维多珠单抗等药物也开始应用于ASUC的治疗.
引文著录 李俊蓉, 凌方梅, 陈翌东, 徐明旸, 朱良如. 急性重症溃疡性结肠炎的治疗. 世界华人消化杂志 2021; 29(2): 87-92
Received
2020-10-28 01:00
Peer-Review Started
2020-10-29 01:17
To Make the First Decision
Return for Revision
2020-11-16 17:07
修回稿
2020-11-24 15:49
Second Decision
2020-12-18 10:08
期刊总编辑接受
公司总编辑接受
2020-12-21 03:07
预出版
2020-12-21 03:07
缴纳版面费
Edit the Manuscript by Language Editor
排版
2021-01-28 02:54
ISSN 1009-3079 (print) and 2219-2859 (online)
开放获取 This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
版权 © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
网址 http://www.wjgnet.com
Assistant Editor 王栋梅
Science Editor 张砚梁
评议人编号 03214638, 03656373, and 03212570
Editorial Director
Journal Chief Editor
Company Chief Editor 王金磊
Language Editor
Production Editor 张砚梁
Responsible Production Editor 张砚梁
Responsible Science Editor
Proofing Editorial Director Jin-Lei Wang
Proofing Editor-in-Chief Lian-Sheng Ma